HEPATOCARCINOGENESIS IN VITRO USING ACTIVATED FOS GENES
HEPATOCARCINOGENESIS IN VITRO USING ACTIVATED FOS GENES
批准号:
3459444
负责人:
RUSSELL M LEBOVITZ
金额:
$8.42万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-03-17 至 1994-02-28
关键词:
DNA binding protein carcinogenesis cell free system enzyme induction /repression fusion gene gene deletion mutation genetic transcription glutathione transferase laboratory rat liver cells liver neoplasms molecular cloning molecular oncology neoplasm /cancer genetics newborn animals oncogenes oncoproteins transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
If we are ever to understand the molecular pathology of neoplasia, a
detailed analysis of the molecular changes brought about by activated
oncogenes must be undertaken within the context of well-characterized
model systems. Expression of activated oncogenes usually results in
complex phenotypic changes including anchorage-independent growth and
tumorigenicity, and it is likely that some of these changes involve a
reprogramming of cellular gene expression by oncogene products. Recent
studies suggest that several oncogene pathways may converge in the
nucleus through the transcriptional activation of specific cellular
genes. It is therefore logical and compelling to analyze directly, at
the molecular level, the effects of a well-characterized nuclear oncogene
(i.e., fos) on the expression of cellular genes whose activity changes
consistently after hepatocarcinogenesis. Newborn-rat liver epithelial
(RLE) cells provide a useful in vitro model system in which to study
molecular mechanisms associated with hepatocarcinogenesis, since
transformation with either chemical carcinogens or an activated ras gene
results in the activation of gamma-glutamyl transpeptidase (gamma GT) and
glutathione-S-transferase-P (GSTP), two markers of liver carcinogenesis
in vivo. I will use a metal-regulatable, metallothionein-c-fos (MTcfos)
fusion gene to transfect RLE cells in culture, to identify any
"transformed" (i.e., anchorage-independent) clones by growth in soft
agarose, and to investigate the correlation between fos-transformation
and the activation of gamma GT and GSTP; preliminary results indicate
that expression of gamma GT but not GSTP is activated after
transformation of RLE cells by low levels of MTcfos. Utilizing the
metal-inducibility of the constructs, I will establish the minimum levels
of MTcfos mRNA (northern blots) and protein (western blots) necessary for
induction of anchorage independent growth, gamma GT expression, and GSTP
expression. During the second phase of these studies, I will analyze in
detail the mechanisms by which the c-fos gene product activates
expression of the gamma GT gene. My efforts will emphasize
transcriptional effects of c-fos, since recent reports suggest that the
c-fos product may bind to transcriptional control sites on DNA. The
following approaches will be used: i) studies in isolated nuclei to
verify transcriptional effects of c-fos; ii) transfection with 5'-
deletion mutants of gamma GT fused to the CAT (chloramphenicol
acetyltransferase) gene to identify fos-dependent regions of the gamma GT
gene; and iii) cell-free transcription of the genomic gamma GT gene to
identify any cellular factors whose activity is required for fos-
dependent activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
-
批准号:9344705
-
项目类别:
-
资助金额:$121.39万
-
财政年份:2016
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
-
批准号:9199717
-
项目类别:
-
资助金额:$125.45万
-
财政年份:2016
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
-
批准号:8670337
-
项目类别:
-
资助金额:$50.23万
-
财政年份:2013
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
-
批准号:8727118
-
项目类别:
-
资助金额:$50.14万
-
财政年份:2013
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
-
批准号:8316922
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2012
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
A nanoparticle prognosticator of chemotherapy outcomes
-
批准号:7744580
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2009
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
NCTX, a novel liposomal CT contrast agent for blood pool imaging
-
批准号:7479688
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2005
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
NCTX, a novel liposomal CT contrast agent for blood pool imaging
-
批准号:7324954
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2005
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6316541
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2000
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6296063
-
项目类别:
-
资助金额:$17.47万
-
财政年份:1999
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6217435
-
项目类别:
-
资助金额:$17.47万
-
财政年份:1999
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6102832
-
项目类别:
-
资助金额:$17.47万
-
财政年份:1999
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6296051
-
项目类别:
-
资助金额:$17.47万
-
财政年份:1999
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6269587
-
项目类别:
-
资助金额:$18.08万
-
财政年份:1998
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6296075
-
项目类别:
-
资助金额:$18.08万
-
财政年份:1998
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
-
批准号:6237331
-
项目类别:
-
资助金额:$17.68万
-
财政年份:1997
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
HEPATOCARCINOGENESIS IN VITRO USING ACTIVATED FOS GENES
-
批准号:3459447
-
项目类别:
-
资助金额:$10.38万
-
财政年份:1989
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
HEPATOCARCINOGENESIS IN VITRO USING ACTIVATED FOS GENES
-
批准号:3459446
-
项目类别:
-
资助金额:$9.9万
-
财政年份:1989
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
HEPATOCARCINOGENESIS IN VITRO USING ACTIVATED FOS GENES
-
批准号:3459445
-
项目类别:
-
资助金额:$9.88万
-
财政年份:1989
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
HEPATOCARCINOGENESIS IN VITRO USING ACTIVATED FOS GENES
-
批准号:2093480
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1989
-
负责人:RUSSELL M LEBOVITZ
-
依托单位:
海外基金